IN-VIVO TREATMENT WITH HEAVY-CHAIN SPECIFIC HC10 MONOCLONAL-ANTIBODY MODULATES DEVELOPMENT OF SPONTANEOUS DISEASE IN HLA-B27 TRANSGENIC MICE

Citation
Sd. Khare et al., IN-VIVO TREATMENT WITH HEAVY-CHAIN SPECIFIC HC10 MONOCLONAL-ANTIBODY MODULATES DEVELOPMENT OF SPONTANEOUS DISEASE IN HLA-B27 TRANSGENIC MICE, Arthritis and rheumatism, 39(9), 1996, pp. 1612-1612
Citations number
NO
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
00043591
Volume
39
Issue
9
Year of publication
1996
Supplement
S
Pages
1612 - 1612
Database
ISI
SICI code
0004-3591(1996)39:9<1612:ITWHSH>2.0.ZU;2-G